Persistent URL of this record https://hdl.handle.net/1887/62736
Documents
-
- Download
- Title page_Table of contents
- open access
-
- Download
- Chapter 2
- open access
- Full text at publishers site
-
- Download
- Chapter 3
- open access
- Full text at publishers site
-
- Download
- Chapter 4
- open access
- Full text at publishers site
-
- Download
- Chapter 5
- open access
- Full text at publishers site
-
- Download
- Chapter 6
- open access
- Full text at publishers site
-
- Download
- Chapter 7
- open access
- Full text at publishers site
-
- Download
- Chapter 8 General discussion
- open access
-
- Download
- Propositions
- open access
In Collections
This item can be found in the following collections:
Forward and reverse genetics strategies for improving oncolytic reoviruses
Oncolytic viruses are highly promising agents for cancer therapy. Reovirus type 3 Dearing and adenovirus type 5 are potent representatives of this new type of treatment. They have been tested in a multitude of clinical trials. In these studies reovirus and adenovirus display a good safety profile, but anti-tumour efficacy should be improved. The work described in this thesis mainly concentrated on improving the entry and spread of reoviruses and adenoviruses in tumours by means of genetic modification of the viruses.
- All authors
- Dautzenberg, I.J.C.
- Supervisor
- Hoeben, R.C.
- Co-supervisor
- Wollenberg, D.J.M. van
- Committee
- Goumans, M.J.T.H.; Dirven, C.M.F.; Pluijm, G. van der; Hoogen, B.G. van den
- Qualification
- Doctor (dr.)
- Awarding Institution
- Medicine / Leiden University Medical Center (LUMC), Leiden University
- Date
- 2018-06-14
- ISBN (print)
- 9789462999251